What’s new in NAFLD pathogenesis, biomarkers and treatment?

Byrne, Christopher and Targher, Giovanni (2020) What’s new in NAFLD pathogenesis, biomarkers and treatment? Nature Reviews Gastroenterology and Hepatology, 17 (2), 70-71. (doi:10.1038/s41575-019-0239-2).

Record type: Article

Abstract

Advances have been made in the field of nonalcoholic fatty liver disease in 2019. One paper highlights the role of gut microbiota in hepatocellular carcinoma (HCC) pathogenesis, another presents a noninvasive algorithm for detecting advanced liver fibrosis and another suggests a potential novel approach to treating nonalcoholic steatohepatitis and suppressing HCC development.

Text

Byrne_Targher accepted for PURE - Accepted Manuscript

Available under License University of Southampton Accepted Manuscript Licence.

Download (193kB)

Text

NAFLD_Figure_Byrne_Targher - Accepted Manuscript

Available under License University of Southampton Accepted Manuscript Licence.

Download (193kB)

More information

Accepted/In Press date: 31 October 2019

e-pub ahead of print date: 18 November 2019

Published date: 1 February 2020

Additional Information: Funding Information: C.D.B. is supported in part by Southampton National Institute for Health Research Biomedical Research Centre, UK. G.T. is supported in part by the University School of Medicine of Verona, Italy. Copyright © 2019, Springer Nature Limited